Dulera

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

36 Suppliers, 15 USDMF, 14 CEP/COS, 4 JDMF, 8 EU WC, 13 KDMF, 22 NDC API, 27 Listed Suppliers

DEVELOPMENTS

23 Drug(s) in Development

23 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

INTERMEDIATES

12 Suppliers

12 Suppliers

DOSSIERs // Finished Dosage Forms

208 Dossiers, 20 FDA Orange Book, 134 Europe, 8 Canada, 4 Australia, 10 South Africa, 32 Listed Dossiers

DRUG PRODUCT COMPOSITION

POWDER;INHALATION - 0.012MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER, METERED;INHALATION - 0.4MG/INH;0.012MG/INH, AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH, AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

RELATED EXCIPIENT COMPANIES

Suppliers, 5 Actylis, 3 Kerry, 2 Nanjing Well Pharmaceutical, 2 BASF, 1 Clariant, 1 Roquette, 1 Microlex e.U, 1 Nippon Fine Chemical, 1 Finar

EXCIPIENTS BY APPLICATIONS

5 Parenteral, 3 Controlled & Modified Release, 3 Co-Processed Excipients, 2 Fillers, Diluents & Binders, 2 Topical, 2 Film Formers & Plasticizers, 2 Granulation, 2 Direct Compression, 2 Emulsifying Agents, 1 Coating Systems & Additives, 1 Thickeners and Stabilizers, 1 Solubilizers, 1 Dry Powder Inhalation, 1 Lubricants & Glidants, 1 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

22 US Medicaid Prescriptions, 84 Finished Drug Prices

MARKET PLACE

12 APIs

12 APIs

PATENTS

40 US Patents

40 US Patents

ANALYTICAL SOLUTION(s)

3 EDQM Standards, 3 USP Standards, 8 Other Ref. Standards

DIGITAL CONTENT

2 Data Compilation & Company Tracker #PharmaFlow, 62 News

Australian Register of Therapeutic Goods list of Approved Drug Products containing Dulera. Original Data : Therapeutic Goods Administration Website

Dulera

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

36 Suppliers

15 USDMF

14 CEP/COS

4 JDMF

8 EU WC

13 KDMF

22 NDC API

27 Listed Suppliers

DEVELOPMENTS

23 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

INTERMEDIATES

12 Suppliers

DOSSIERs // Finished Dosage Forms

208 Dossiers

20 FDA Orange Book

134 Europe

8 Canada

4 Australia

10 South Africa

32 Listed Dossiers

DRUG PRODUCT COMPOSITION

POWDER;INHALATION - 0.012MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

POWDER, METERED;INHALATION - 0.4MG/INH;0.012MG/INH

AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH

AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH

AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH

AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

RELATED EXCIPIENT COMPANIES

Suppliers

5 Actylis

3 Kerry

2 Nanjing Well Pharmaceutical

2 BASF

1 Clariant

1 Roquette

1 Microlex e.U

1 Nippon Fine Chemical

1 Finar

EXCIPIENTS BY APPLICATIONS

5 Parenteral

3 Controlled & Modified Release

3 Co-Processed Excipients

2 Fillers, Diluents & Binders

2 Topical

2 Film Formers & Plasticizers

2 Granulation

2 Direct Compression

2 Emulsifying Agents

1 Coating Systems & Additives

1 Thickeners and Stabilizers

1 Solubilizers

1 Dry Powder Inhalation

1 Lubricants & Glidants

1 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

22 US Medicaid Prescriptions

84 Finished Drug Prices

MARKET PLACE

12 APIs

PATENTS

40 US Patents

ANALYTICAL SOLUTION(s)

3 EDQM Standards

3 USP Standards

8 Other Ref. Standards

DIGITAL CONTENT

2 Data Compilation & Company Tracker #PharmaFlow

62 News

Aclidinium; Formoterol

POWDER;INHALATION - 0.012MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons